Novel immunotherapies in multiple myeloma – chances and challenges
In this review article, we summarize the latest data on antibody-drug conjugates, bispecific T-cell-engaging antibodies, and chimeric antigen receptor T cells in the treatment of multiple myeloma. We discuss the pivotal questions to be addressed as these new immunotherapies become standard agents i...
保存先:
| 主要な著者: | , , , , |
|---|---|
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
Ferrata Storti Foundation
2021-07-01
|
| シリーズ: | Haematologica |
| オンライン･アクセス: | https://haematologica.org/article/view/10313 |
| タグ: |
タグなし, このレコードへの初めてのタグを付けませんか!
|